Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHEK1 | O14757 | 1/20 | 0.47 |
| ▸ | AKT1 | P31749 | 8/20 | 0.44 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.43 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.43 |
| ▸ | LIMK1 | P53667 | 3/20 | 0.40 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.40 |
| ▸ | KHK | P50053 | 1/20 | 0.39 |
| ▸ | KIT | P10721 | 1/20 | 0.39 |
| ▸ | BRAF | P15056 | 1/20 | 0.38 |
| ▸ | TNNI3K | Q59H18 | 1/20 | 0.38 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.36 |
| ▸ | CCNK | O75909 | 1/20 | 0.36 |
| ▸ | CDK12 | Q9NYV4 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22912722 | 0.79 | CHEK1 (0.66) | CHEK1AKT1TRPA1IRAK4LIMK1 | |
| SCHEMBL9967152 | 0.79 | AKT1 (0.46) | CHEK1AKT1TRPA1IRAK4LIMK1 | |
| SCHEMBL10259826 | 0.78 | AKT1 (0.45) | CHEK1AKT1TRPA1IRAK4LIMK1 | |
| SCHEMBL1804027 | 0.76 | AKT1 (0.44) | CHEK1AKT1TRPA1IRAK4LIMK1 | |
| SCHEMBL357993 | 0.76 | CHEK1 (0.61) | CHEK1AKT1TRPA1IRAK4LIMK1 | |
| SCHEMBL27636535 | 0.73 | IRAK4 (0.51) | CHEK1AKT1TRPA1IRAK4LIMK1 | |
| SCHEMBL14330947 | 0.73 | AKT1 (0.44) | CHEK1AKT1TRPA1IRAK4LIMK1 | |
| SCHEMBL17032328 | 0.73 | AKT1 (0.42) | CHEK1AKT1TRPA1IRAK4LIMK1 | |
| SCHEMBL2537071 | 0.72 | CHEK1 (0.61) | CHEK1AKT1TRPA1IRAK4LIMK1 | |
| SCHEMBL2600520 | 0.72 | AKT1 (0.38) | AKT1TRPA1IRAK4LIMK1ROCK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2922596-B1 | HETEROCYCLYL CARBOXAMIDES FOR TREATING VIRAL DISEASES | NOVADRUG LLC (US) | 2018-05-23 | — | — | EP | disclosed |